Clinical Trials Directory

Trials / Recruiting

RecruitingNCT04872179

International Registry of Patients With Alpha Thalassemia

International Prospective Registry of Patients With Alpha Thalassemia

Status
Recruiting
Phase
Study type
Observational
Enrollment
500 (estimated)
Sponsor
University of California, San Francisco · Academic / Other
Sex
All
Age
Healthy volunteers
Not accepted

Summary

This is an international prospective registry of patients with Alpha thalassemia to understand the natural history of the disease and the outcomes of fetal therapies, with the overall goal of improving the prenatal management of patients with Alpha thalassemia.

Detailed description

The aim of this registry is to prospectively and retrospectively collect data on patients who are diagnosed with alpha thalassemia major and other alpha thalassemia mutations. Data collected will be used to: 1. Identify patient outcomes of therapies. 2. Improve clinical management of patients with ATM. 3. Improve medical decision making. 4. Improve quality of care.

Conditions

Timeline

Start date
2017-01-01
Primary completion
2027-01-01
Completion
2037-01-01
First posted
2021-05-04
Last updated
2025-04-04

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT04872179. Inclusion in this directory is not an endorsement.